Lazard Asset Management
FATE icon

Lazard Asset Management’s Fate Therapeutics FATE Stock Holding History

Lazard Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-89,403
Closed -$901K – 2378
2022
Q4 		$901K Sell
89,403
-71,970
-45% -$1.35M ﹤0.01% 1018
2022
Q3 		$3.62M Sell
161,373
-59,987
-27% -$1.73M 0.01% 774
2022
Q2 		$5.49M Buy
221,360
+76,571
+53% +$2.11M 0.01% 723
2022
Q1 		$5.61M Buy
144,789
+36,797
+34% +$1.42M 0.01% 736
2021
Q4 		$6.32M Buy
107,992
+62,310
+136% +$3.53M 0.01% 733
2021
Q3 		$2.71M Sell
45,682
-27,105
-37% -$2.13M ﹤0.01% 875
2021
Q2 		$6.32M Buy
72,787
+70,507
+3,092% +$5.68M 0.01% 686
2021
Q1 		$187K Buy
2,280
+697
+44% +$66.8K ﹤0.01% 1110
2020
Q4 		$143K Buy
+1,583
New +$98.3K ﹤0.01% 1136
2020
Q3 		– Sell
-117
Closed -$4K – 1645
2020
Q2 		$4K Buy
+117
New +$3.49K ﹤0.01% 1532

Other funds holding FATE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return